Ebstein's anomaly of the tricuspid valve: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 191: Line 191:


==References==
==References==
{{Reflist}}
==Additional Resources==
* Emma C. Ferguson, Rajesh Krishnamurthy, and Sandra A. A. Oldham. [http://radiographics.rsnajnls.org/cgi/content/abstract/27/5/1323 Classic Imaging Signs of Congenital Cardiovascular Abnormalities.] RadioGraphics 2007 27: 1323-1334.
* Emma C. Ferguson, Rajesh Krishnamurthy, and Sandra A. A. Oldham. [http://radiographics.rsnajnls.org/cgi/content/abstract/27/5/1323 Classic Imaging Signs of Congenital Cardiovascular Abnormalities.] RadioGraphics 2007 27: 1323-1334.
* Joris P. A. Beerepoot, and Pamela K. Woodard. [http://radiology.rsnajnls.org/cgi/content/full/231/3/747 Case 71: Ebstein Anomaly]. Radiology 2004 231: 747-751.
* Joris P. A. Beerepoot, and Pamela K. Woodard. [http://radiology.rsnajnls.org/cgi/content/full/231/3/747 Case 71: Ebstein Anomaly]. Radiology 2004 231: 747-751.

Revision as of 15:36, 19 March 2009

Ebstein's anomaly of the tricuspid valve
Chest X-ray of a patient with Ebstein's anomaly
Image courtesy of RadsWiki
ICD-10 Q22.5
ICD-9 746.2
OMIM 224700
DiseasesDB 4039
eMedicine med/627 
MeSH D004437

WikiDoc Resources for Ebstein's anomaly of the tricuspid valve

Articles

Most recent articles on Ebstein's anomaly of the tricuspid valve

Most cited articles on Ebstein's anomaly of the tricuspid valve

Review articles on Ebstein's anomaly of the tricuspid valve

Articles on Ebstein's anomaly of the tricuspid valve in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Ebstein's anomaly of the tricuspid valve

Images of Ebstein's anomaly of the tricuspid valve

Photos of Ebstein's anomaly of the tricuspid valve

Podcasts & MP3s on Ebstein's anomaly of the tricuspid valve

Videos on Ebstein's anomaly of the tricuspid valve

Evidence Based Medicine

Cochrane Collaboration on Ebstein's anomaly of the tricuspid valve

Bandolier on Ebstein's anomaly of the tricuspid valve

TRIP on Ebstein's anomaly of the tricuspid valve

Clinical Trials

Ongoing Trials on Ebstein's anomaly of the tricuspid valve at Clinical Trials.gov

Trial results on Ebstein's anomaly of the tricuspid valve

Clinical Trials on Ebstein's anomaly of the tricuspid valve at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Ebstein's anomaly of the tricuspid valve

NICE Guidance on Ebstein's anomaly of the tricuspid valve

NHS PRODIGY Guidance

FDA on Ebstein's anomaly of the tricuspid valve

CDC on Ebstein's anomaly of the tricuspid valve

Books

Books on Ebstein's anomaly of the tricuspid valve

News

Ebstein's anomaly of the tricuspid valve in the news

Be alerted to news on Ebstein's anomaly of the tricuspid valve

News trends on Ebstein's anomaly of the tricuspid valve

Commentary

Blogs on Ebstein's anomaly of the tricuspid valve

Definitions

Definitions of Ebstein's anomaly of the tricuspid valve

Patient Resources / Community

Patient resources on Ebstein's anomaly of the tricuspid valve

Discussion groups on Ebstein's anomaly of the tricuspid valve

Patient Handouts on Ebstein's anomaly of the tricuspid valve

Directions to Hospitals Treating Ebstein's anomaly of the tricuspid valve

Risk calculators and risk factors for Ebstein's anomaly of the tricuspid valve

Healthcare Provider Resources

Symptoms of Ebstein's anomaly of the tricuspid valve

Causes & Risk Factors for Ebstein's anomaly of the tricuspid valve

Diagnostic studies for Ebstein's anomaly of the tricuspid valve

Treatment of Ebstein's anomaly of the tricuspid valve

Continuing Medical Education (CME)

CME Programs on Ebstein's anomaly of the tricuspid valve

International

Ebstein's anomaly of the tricuspid valve en Espanol

Ebstein's anomaly of the tricuspid valve en Francais

Business

Ebstein's anomaly of the tricuspid valve in the Marketplace

Patents on Ebstein's anomaly of the tricuspid valve

Experimental / Informatics

List of terms related to Ebstein's anomaly of the tricuspid valve

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] and Claudia P. Hochberg, M.D. [2]

Contributors: Cafer Zorkun M.D. PhD.

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Ebstein's anomaly is a congenital heart defect in which the opening of the tricuspid valve is displaced towards the apex of the right ventricle of the heart (congenital apical displacement of the tricuspid valve that typically causes significant tricuspid regurgitation).

The annulus of the valve is in normal position. The valve leaflets however, are to a varying degree attached to the walls and septum of the right ventricle. There is subsequent atrialization of a portion of the morphologic right ventricle (which is then contiguous with the right atrium). This causes the right atrium to be large and the anatomic right ventricle to be small in size. 50% of cases involve an atrial shunt (either a PFO or an ASD).

History

Ebstein's anomaly was named after Wilhelm Ebstein.[1][2]

Associated Abnormalities

While Ebstein's anomaly is defined as the congenital displacement of the tricuspid valve towards the apex of the right ventricle, it is often associated with other abnormalities.

Anatomy

Typically, there are anatomic abnormalities of the tricuspid valve, with enlargement of the anterosuperior leaflet of the valve which is often adherent to the right ventricular free wall.

About 50% of individuals with Ebstein's anomaly have an associated shunt between the right and left atriums, either an atrial septal defect ASD or a patent foramen ovale PFO.

- The tricuspid valve leaflets are displaced toward the RV apex.

- The RV cavity is dilated and the free wall is thin.

- May be associated with LV dysfunction and mitral valve prolapse (MVP).

- It has also been associated with pulmonic stenosis (PS), VSD, pulmonary hypertension, bicuspid aortic valve and right sided aortic arch.

-It is commonly associated with congenitally corrected transposition of the great vessels and occasionally with tetralogy of Fallot.

- Is often associated with one or more accessory conduction pathways in 25%, and WPW in 13%. Usually this is a right sided accessory pathway.

- The presence of an ASD permits right-to-left shunting and cyanosis. The degree of cyanosis is related to the degree of tricuspid regurgitation (TR), tricuspid stenosis (TS) and the compliance of the RV.

Epidemiology and Demographics

  • Is a rare congenital heart disease.
  • About 1:1,000 patients with congenital heart disease, or 1:210,000 live births.
  • Males = females.
  • Higher incidence in infants whose mothers are treated with Lithium Carbonate during pregnancy

Genetics

  • Multifactorial inheritance, risk if a sibling has the disease is 1%.

Diagnosis

History

  • Presentation depends greatly on the degree of apical displacement of the tricuspid valve leaflet as well as the degree of dysfunction of the tricuspid valve. If the tricuspid valve is severely deformed, fetal hydrops may occur. If the valve is functioning, patients may remain symptom free for many years.
  • The majority of patients have dyspnea and cyanosis (40%) but some may be asymptomatic.
  • Growth and development are normal.

Physical Examination

General Appearance

Patients may have a bluish coloration of their face depending on the degree of cyanosis and right to left shunting.

Heart

Because the RA is dilated and compliant, there are no large v waves even in the presence of TR (tricuspid regurgitation) and the jugular venous pressure is often normal on exam. The chest may be asymmetric due to an enlarged right heart.

The first heart sound is widely split. There is a wide split S2 as a result of RBBB and delayed closure of the pulmonic valve. TR (tricuspid regurgitation), produces a holosystolic murmur which is heard best along the left lower sternal border and increases with inspiration.

Laboratory Findings

Electrocardiogram

The EKG is abnormal in 50 to 67%.

About 50% of individuals with Ebstein's anomaly have evidence of Wolff-Parkinson-White Syndrome (syndrome of pre-excitation of the ventricles due to an accessory pathway known as the Bundle of Kent), secondary to the the apical displacement of the septal tricuspid valve leaflet resulting in discontinuity of the central fibrous body.

10-lead ECG of a woman with Ebstein's anomaly. The ECG shows signs of right atrial enlargement, best seen in V1. Other P waves are broad and tall, these are termed "Himalayan" P waves. There is also a right bundle branch block pattern and a first degree atrioventricular block (prolonged PR-interval) due to intra-atrial conduction delay. There is no evidence of a Kent-bundle in this patient. There is T wave inversion in V1-4 and a marked Q wave in III; these changes are characteristic for Ebstein's anomaly and do not reflect ischemic ECG changes in this patient.


Other abnormalities that can be seen on the ECG include:[3]

(1) signs of right atrial enlargement or tall and broad 'Himalayan' P waves,

(2) first degree atrioventricular block manifesting as a prolonged PR-interval,

(3) low amplitude QRS complexes in the right precordial leads,

(4) atypical right bundle branch block,

(5) T wave inversion in V1-V4 and Q waves in V1-V4 and II, III and aVF.

(6) a short PR interval and a delta wave and low voltages.

Chest X Ray

The Chest X-ray shows a balloon shaped heart that looks a lot like a pericardial effusion. The RA is dilated. The heart looks globular.

Chest x-ray of a patient with Ebstein anomaly


Echocardiogram

See Echo in Ebstein's anomaly of the tricuspid valve for more info/images

a) Can be used to assess the severity of dilatation of the right atrium, and the functional status of the tricuspid valve as well as the right ventricle.

b) Normally the tricuspid valve closes within 30 msec of the mitral valve. In Ebstein's, the tricuspid valve closes 50 to 60 msec after the mitral valve.

c) The delayed tricuspid closure is not due to RBBB because it also occurs with preexcitation.

d) 2D ECHO allows you to assess whether the repair can be accomplished without a prosthetic valve, and detects whether an interatrial shunt is present.

Pathological specimen and ultrasound image of a heart with Ebstein's anomaly. Abbreviations: RA: Right atrium; ARV: Atrialized right ventricle; FRV: Functional right ventricle; AL: Anterior leaflet; SL: Septal leaflet; LA: Left atrium; LV: Left ventricle; asterisk: grade II tethering of the tricuspid septal leaflet.


Below is an apical 4-chamber transthoracic view, showing apically-displaced leaflets of the tricuspid valve. Note substantial tricuspid regurgitation, which originates close to the apex, where the abnormal leaflets actually coapt:

<Youtube v=KEko3kM26bY/>

CT and MRI

Inferior displacement of tricuspid valve leaflets with enlargement of the right atrium and enlargement and dysfunction of the right ventricle.

Cardiac catheterization and hemodynamics

a) RA pressure usually not increased due to the fact that the RA is enlarged and compliant.

b) Normal RV pressures unless significant TR is present.

c) PA pressures are normal or slightly decreased due to TR and a large right-to-left shunt.

d) An ASD may be present

Treatment

Mechanical and Device Based Therapy

The protracted natural history of this disease in contrast to the uncertainty of long-term results of surgical intervention supports the policy of postponing surgical intervention until the onset of disability.

Surgery may include

- Tricuspid valve repair or replacement (when possible repair is preferable to replacement as it is associated with a lower mortality rate and fewer complications).

  • Atrial septal defect repair.
  • Right atrial plication (unclear whther this improves right ventricular function).
  • Cardiac defibrillator implantation.
  • Accessory pathways may require surgical intervention or ablation.

Hospital mortality at the Mayo for valve reconstruction is 6.7%. Only 1.6% in the Mayo series required reoperation. Long term follow up in the Mayo series showed 92% to have Class I or II symptoms and a 10 year mortality rate of 8%.

Generally, surgical treatment improves the exercise intolerance from NYHA-FC III or IV to NYHA-FC I or II.

Regardless of severity of the Ebstein’s Anomaly and type of treatment, risk of sudden death remains an important issue in patients with Ebstein's anomaly.

Prognosis

Adverse prognostic factors are

a) NYHA Class III or IV

b) Moderate to severe cardiomegaly

c) Cyanosis or an O2 sat < 90%

d) Disability during infancy

e)Paradoxical emboli

References

  1. Template:WhoNamedIt
  2. W. Ebstein. Über einen sehr seltenen Fall von Insufficienz der Valvula tricuspidalis, bedingt durch eine angeborene hochgradige Missbildung derselben. Archiv für Anatomie, Physiologie und wissenschaftliche Medicin, Leipzig, 1866, 238-254.
  3. Khairy P, Marelli AJ (2007). "Clinical use of electrocardiography in adults with congenital heart disease". Circulation. 116 (23): 2734–46. doi:10.1161/CIRCULATIONAHA.107.691568. PMID 18056539. Unknown parameter |month= ignored (help)

Additional Resources

External Links

Acknowledgements and Initial Contributors to Page

Leida Perez, M.D.

Template:SIB


Template:WikiDoc Sources